This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Novel hybrid devices combine magnetic resonance imaging (MRI) and a linear accelerator in a single device. The superior soft tissue contrast compared with cone-beam computed tomography based treatment and the possibility for daily plan adaptation promise a higher precision of treatment, better target volume coverage and normal tissue sparing. In a first step the present study will test the feasibility of imaging and treatment on the 1.5 T MR-Linac.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
472
Radiotherapy is performed on the 1.5 T MR Linac
Only imaging performed on the MR Linac
University Hospital Tübingen, Department of Radiation Oncology
Tübingen, Baden-Wurttemberg, Germany
RECRUITINGFeasibility of online MR guided Radiotherapy
Treatment of a patient is considered feasible when 85% of treatments were completed as planned in this patient
Time frame: During every single patients treatment (i.e. between one to seven weeks after the first application of radiotherapy)
Time analysis
Time required for online MR guided radiotherapy
Time frame: During every single patients treatment (i.e. between one to seven weeks after the first application of radiotherapy)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.